FONR
FONAR Corporation
Medical - Devices
Market Cap$124M
5Y Perf.+12.7%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
FONR vs GEHC
Revenue, margins, valuation, and 5-year total return — side by side.
GEHC
GE HealthCare Technologies Inc.
Medical - Healthcare Information Services
Market Cap$27.90B
5Y Perf.+5.1%
FONR vs GEHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | FONR | GEHC |
|---|---|---|
| Industry | Medical - Devices | Medical - Healthcare Information Services |
| Market Cap | $124M | $27.90B |
| Revenue (TTM) | $106M | $19.95B |
| Net Income (TTM) | $8M | $1.50B |
| Gross Margin | 40.8% | 42.5% |
| Operating Margin | 10.1% | 12.5% |
| Forward P/E | 15.3x | 12.4x |
| Total Debt | $39M | $10.00B |
| Cash & Equiv. | $56M | $4.51B |
FONR vs GEHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
FONR
GEHC
| Stock | Dec 22 | May 26 | Return |
|---|---|---|---|
| FONAR Corporation (FONR) | 100 | 112.7 | +12.7% |
| GE HealthCare Techn… (GEHC) | 100 | 105.1 | +5.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FONR vs GEHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: GEHC leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. FONAR Corporation is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
FONR
FONAR Corporation
The Income Pick
FONR is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.10
- 35.0% 10Y total return vs GEHC's 2.9%
- Lower volatility, beta 0.10, Low D/E 24.3%, current ratio 8.45x
Best for: income & stability and long-term compounding
GEHC
GE HealthCare Technologies Inc.
The Growth Play
GEHC carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 4.8%, EPS growth 4.8%, 3Y rev CAGR 4.0%
- 4.8% revenue growth vs FONR's 1.4%
- Lower P/E (12.4x vs 15.3x)
Best for: growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | GEHC | 4.8% revenue growth vs FONR's 1.4% |
| Value | GEHC | Lower P/E (12.4x vs 15.3x) |
| Quality / Margins | GEHC | 7.5% margin vs FONR's 7.1% |
| Stability / Safety | FONR | Beta 0.10 vs GEHC's 1.37, lower leverage |
| Dividends | GEHC | 0.2% yield; 3-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | FONR | +53.4% vs GEHC's -10.7% |
| Efficiency (ROA) | GEHC | 4.1% ROA vs FONR's 3.5%, ROIC 13.3% vs 6.1% |
FONR vs GEHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FONR vs GEHC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLFONRLAGGINGGEHC
GEHCGE HealthCare Technol…
2leads
FONRFONAR Corporation
4leads
6 Total Categories
CATEGORYLEADERvs GEHCMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
GEHC5/6
Valuation MetricsMultiples, price ratios, and targets
FONR4/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
FONR5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
FONR6/6
Risk & VolatilityBeta, volatility, and downside exposure
FONR2/2
Analyst OutlookRatings, price targets, and dividends
GEHC1/1
Income & Cash Flow (Last 12 Months)
GEHC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC is the larger business by revenue, generating $20.0B annually — 188.2x FONR's $106M. Profitability is closely matched — net margins range from 7.5% (GEHC) to 7.1% (FONR). On growth, GEHC holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | FONRFONAR Corporation | GEHCGE HealthCare Tec… |
|---|---|---|
| RevenueTrailing 12 months | $106M | $20.0B |
| EBITDAEarnings before interest/tax | $15M | $3.3B |
| Net IncomeAfter-tax profit | $8M | $1.5B |
| Free Cash FlowCash after capex | $6M | $1.5B |
| Gross MarginGross profit ÷ Revenue | +40.8% | +42.5% |
| Operating MarginEBIT ÷ Revenue | +10.1% | +12.5% |
| Net MarginNet income ÷ Revenue | +7.1% | +7.5% |
| FCF MarginFCF ÷ Revenue | +5.4% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.4% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.9% | -30.9% |
GEHC leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
FONR leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, GEHC trades at a 12% valuation discount to FONR's 15.3x P/E. On an enterprise value basis, FONR's 6.5x EV/EBITDA is more attractive than GEHC's 10.0x.
| Metric | FONRFONAR Corporation | GEHCGE HealthCare Tec… |
|---|---|---|
| Market CapShares × price | $124M | $27.9B |
| Enterprise ValueMkt cap + debt − cash | $106M | $33.4B |
| Trailing P/EPrice ÷ TTM EPS | 15.35x | 13.48x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 19.78x |
| EV / EBITDAEnterprise value multiple | 6.52x | 10.00x |
| Price / SalesMarket cap ÷ Revenue | 1.19x | 1.35x |
| Price / BookPrice ÷ Book value/share | 0.77x | 2.66x |
| Price / FCFMarket cap ÷ FCF | 16.61x | 18.53x |
FONR leads this category, winning 4 of 5 comparable metrics.
Profitability & Efficiency
FONR leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $4 for FONR. FONR carries lower financial leverage with a 0.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEHC's 0.94x. On the Piotroski fundamental quality scale (0–9), FONR scores 7/9 vs GEHC's 4/9, reflecting strong financial health.
| Metric | FONRFONAR Corporation | GEHCGE HealthCare Tec… |
|---|---|---|
| ROE (TTM)Return on equity | +4.3% | +14.4% |
| ROA (TTM)Return on assets | +3.5% | +4.1% |
| ROICReturn on invested capital | +6.1% | +13.3% |
| ROCEReturn on capital employed | +5.9% | +10.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.24x | 0.94x |
| Net DebtTotal debt minus cash | -$17M | $5.5B |
| Cash & Equiv.Liquid assets | $56M | $4.5B |
| Total DebtShort + long-term debt | $39M | $10.0B |
| Interest CoverageEBIT ÷ Interest expense | 705.24x | 5.35x |
FONR leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
FONR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FONR five years ago would be worth $10,983 today (with dividends reinvested), compared to $10,293 for GEHC. Over the past 12 months, FONR leads with a +53.4% total return vs GEHC's -10.7%. The 3-year compound annual growth rate (CAGR) favors FONR at 4.6% vs GEHC's -8.0% — a key indicator of consistent wealth creation.
| Metric | FONRFONAR Corporation | GEHCGE HealthCare Tec… |
|---|---|---|
| YTD ReturnYear-to-date | +1.9% | -25.9% |
| 1-Year ReturnPast 12 months | +53.4% | -10.7% |
| 3-Year ReturnCumulative with dividends | +14.3% | -22.2% |
| 5-Year ReturnCumulative with dividends | +9.8% | +2.9% |
| 10-Year ReturnCumulative with dividends | +35.0% | +2.9% |
| CAGR (3Y)Annualised 3-year return | +4.6% | -8.0% |
FONR leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
FONR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FONR is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than GEHC's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FONR currently trades 99.6% from its 52-week high vs GEHC's 68.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | FONRFONAR Corporation | GEHCGE HealthCare Tec… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.10x | 1.37x |
| 52-Week HighHighest price in past year | $18.95 | $89.77 |
| 52-Week LowLowest price in past year | $12.17 | $58.75 |
| % of 52W HighCurrent price vs 52-week peak | +99.6% | +68.3% |
| RSI (14)Momentum oscillator 0–100 | 67.7 | 32.1 |
| Avg Volume (50D)Average daily shares traded | 52K | 4.3M |
FONR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
GEHC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
GEHC is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | FONRFONAR Corporation | GEHCGE HealthCare Tec… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $84.00 |
| # AnalystsCovering analysts | — | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | 0 | 3 |
| Dividend / ShareAnnual DPS | — | $0.14 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +0.7% |
GEHC leads this category, winning 1 of 1 comparable metric.
Key Takeaway
FONR leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). GEHC leads in 2 (Income & Cash Flow, Analyst Outlook).
Best OverallFONAR Corporation (FONR)Leads 4 of 6 categories
Loading custom metrics...
FONR vs GEHC: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is FONR or GEHC a better buy right now?
For growth investors, GE HealthCare Technologies Inc.
(GEHC) is the stronger pick with 4. 8% revenue growth year-over-year, versus 1. 4% for FONAR Corporation (FONR). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate GE HealthCare Technologies Inc. (GEHC) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FONR or GEHC?
On trailing P/E, GE HealthCare Technologies Inc.
(GEHC) is the cheapest at 13. 5x versus FONAR Corporation at 15. 3x.
03Which is the better long-term investment — FONR or GEHC?
Over the past 5 years, FONAR Corporation (FONR) delivered a total return of +9.
8%, compared to +2. 9% for GE HealthCare Technologies Inc. (GEHC). Over 10 years, the gap is even starker: FONR returned +35. 0% versus GEHC's +2. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FONR or GEHC?
By beta (market sensitivity over 5 years), FONAR Corporation (FONR) is the lower-risk stock at 0.
10β versus GE HealthCare Technologies Inc. 's 1. 37β — meaning GEHC is approximately 1210% more volatile than FONR relative to the S&P 500. On balance sheet safety, FONAR Corporation (FONR) carries a lower debt/equity ratio of 24% versus 94% for GE HealthCare Technologies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FONR or GEHC?
By revenue growth (latest reported year), GE HealthCare Technologies Inc.
(GEHC) is pulling ahead at 4. 8% versus 1. 4% for FONAR Corporation (FONR). On earnings-per-share growth, the picture is similar: GE HealthCare Technologies Inc. grew EPS 4. 8% year-over-year, compared to -19. 6% for FONAR Corporation. Over a 3-year CAGR, GEHC leads at 4. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FONR or GEHC?
GE HealthCare Technologies Inc.
(GEHC) is the more profitable company, earning 10. 1% net margin versus 8. 0% for FONAR Corporation — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEHC leads at 13. 4% versus 11. 1% for FONR. At the gross margin level — before operating expenses — FONR leads at 81. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — FONR or GEHC?
In this comparison, GEHC (0.
2% yield) pays a dividend. FONR does not pay a meaningful dividend and should not be held primarily for income.
08Is FONR or GEHC better for a retirement portfolio?
For long-horizon retirement investors, FONAR Corporation (FONR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
10)). Both have compounded well over 10 years (FONR: +35. 0%, GEHC: +2. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between FONR and GEHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(FONR: 2.4% · GEHC: 7.4%)Net Margin>
%
(FONR: 7.1% · GEHC: 7.5%)P/E Ratio<
x
(FONR: 15.3x · GEHC: 13.5x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.